Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from N2OFF ( (NITO) ) is now available.
On September 25, 2025, N2OFF held a special general meeting where stockholders approved the acquisition of MitoCareX Bio Ltd., a biotech company specializing in drug discovery for resistant cancers. This acquisition aligns with N2OFF’s strategic expansion into the biotech sector, potentially enhancing its market position by diversifying its portfolio. The acquisition agreement includes financial commitments to support MitoCareX’s operations and milestone-based stock issuances, with the transaction expected to close by mid-October 2025.
More about N2OFF
N2OFF is a cleantech company primarily engaged in investing in solar energy assets in the EU using the Ready to Build (RTB) business model. The company is the lead investor in multiple solar projects across three EU countries and also controls Save Foods Ltd., which focuses on post-harvest treatments for fruits and vegetables to prevent pathogen contamination.
Average Trading Volume: 48,695
Technical Sentiment Signal: Strong Sell
Current Market Cap: $5.17M
See more data about NITO stock on TipRanks’ Stock Analysis page.